Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Tdf

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04135235Unknown

Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B

NCT01337791Phase 4Completed

Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels

Showing all 2 trials

Research Network

Common Treatments

  • Tdf1
  • Telbivudine1
  • Taf1

Active Sponsors

  • Beijing Ditan Hospital1
  • Southeast University, China1

Top Investigators

Related Conditions

  • Chronic Hepatitis B Infection1
  • Pregnancy Complications1
  • Elevated Alanine Aminotransferase Levels1
  • Chronic Hepatitis B1

Activity Timeline